Sumitomo Mitsui Trust Holdings, Inc. Repligen Corp Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 97,513 shares of RGEN stock, worth $13.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
97,513
Previous 107,109
8.96%
Holding current value
$13.9 Million
Previous $19.7 Million
37.6%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.08 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$724 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$659 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$248 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$203 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.93B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....